Fluticasone propionate and Salmeterol
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
69097-663 -
Package NDC
69097-663-03 -
Application number
ANDA213087 -
SPL ID
6a4f271b-bc4d-4e04-b5d2-d8e8a48d7215 -
SPL set ID
1349a04c-2024-42b9-b81d-a7d995716ade -
UNII
O2GMZ0LF5W -
UNII
6EW8Q962A5 -
RxCUI
896184 -
RxCUI
896209 -
RxCUI
896228
What the source publishes
- Labeler
- Cipla USA Inc.
- Active ingredients
- Fluticasone propionate and Salmeterol
- Form
- POWDER
- Routes
- RESPIRATORY (INHALATION)
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Fluticasone propionate and Salmeterol",
"splId": "6a4f271b-bc4d-4e04-b5d2-d8e8a48d7215",
"labels": [
{
"setId": "1349a04c-2024-42b9-b81d-a7d995716ade",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1349a04c-2024-42b9-b81d-a7d995716ade",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1349a04c-2024-42b9-b81d-a7d995716ade"
}
],
"routes": [
"RESPIRATORY (INHALATION)"
],
"labeler": "Cipla USA Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 INHALER in 1 CARTON (69097-663-03) / 60 POWDER in 1 INHALER",
"package_ndc": "69097-663-03",
"identifierStatus": "well-formed",
"marketing_start_date": "20260727"
}
],
"productId": "69097-663_6a4f271b-bc4d-4e04-b5d2-d8e8a48d7215",
"useDomain": "unknown",
"dosageForm": "POWDER",
"productNdc": "69097-663",
"deaSchedule": null,
"genericName": "Fluticasone propionate and Salmeterol",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "FLUTICASONE PROPIONATE",
"strength": "500 ug/1"
},
{
"name": "SALMETEROL XINAFOATE",
"strength": "50 ug/1"
}
],
"applicationNumber": "ANDA213087",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20260727",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"unii": [
"O2GMZ0LF5W",
"6EW8Q962A5"
],
"rxcui": [
"896184",
"896209",
"896228"
],
"spl_set_id": [
"1349a04c-2024-42b9-b81d-a7d995716ade"
],
"manufacturer_name": [
"Cipla USA Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:69097-663_6a4f271b-bc4d-4e04-b5d2-d8e8a48d7215"